MagQu focuses on creating new technologies and novel products. To do this, MagQu forms an interdisciplinary R&D team, as well as cooperates with professional institutes or experts in the areas of bio-chemistry, protein, nanomaterials, magnetism, electric engineering, software programming, laboratory medicine, clinic medicine, aquaculture etc. So far, MagQu has created more than six innovative technologies and has made them commercialized. Through the marketing of these novel products, we continuously increases its value, and keeps itself at the leading position in the relevant markets. We have utilized our core technology, so-called ImmunoMagnetic Reduction (IMR), to develop dozens of products, such as in-vitro diagnostic (IVD) assay kits and analyzers for colorectal cancer, Alzheimer’s disease, Down’s syndrome, preterm birth, inflammatory disease, grouper viruses etc. The R&D and manufacture of products have been certified with both ISO including 9001 and 13485, and GMP. We successfully made them on the shelf for life-science markets in China, Japan, Korea, Malaysia, Turkey, USA, UK, and Germany.
View Top Employees from MagQu Co., Ltd.Website | http://www.magqu.com |
Revenue | $6 million |
Employees | 11 (4 on RocketReach) |
Founded | 2008 |
Phone | (623) 792-8888 |
Technologies |
JavaScript,
HTML,
Google Analytics
+9 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering |
Competitors | Boster Biological Technology, Nelson Lab, ProMab Biotechnologies, Inc., Sympros, Inc |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular MagQu Co., Ltd. employee's phone or email?
The MagQu Co., Ltd. annual revenue was $6 million in 2024.
4 people are employed at MagQu Co., Ltd..
The NAICS codes for MagQu Co., Ltd. are [54171, 541, 541714, 54, 5417].
The SIC codes for MagQu Co., Ltd. are [87, 873].